Article
Cellular and molecular aspects of pancreatic cancer.
Acta histochemica - 1 Apr 2016
Gharibi A, Adamian Y, Kelber J A
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy that affects nearly 50,000 patients each year. The overall 5-year survival rate for this malignancy remains the lowest of any cancer at around 7% due to limited diagnostic methods, disease aggressiveness and a lack of targeted therapeutic interventions. This review highlights the successes achieved over the past several decades as well as the...
Topics
- Animals
- Carcinogenesis
- Carcinoma, Pancreatic Ductal
- Humans
- Mutation
- Pancreatic Neoplasms
